These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2969902)

  • 1. The progression of diabetic nephropathy in type I diabetics: relationship to metabolic control and blood pressure.
    Zander E; Schulz B; Mester J; Jutzi E; Templin R; Conde N
    J Diabet Complications; 1987; 1(2):53-7. PubMed ID: 2969902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus.
    Biesenbach G; Janko O; Zazgornik J
    Nephrol Dial Transplant; 1994; 9(8):1097-102. PubMed ID: 7800207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncontrolled hypertension is associated with a rapid progression of nephropathy in type 2 diabetic patients with proteinuria and preserved renal function.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Tohoku J Exp Med; 1990 Aug; 161(4):311-8. PubMed ID: 2256104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in blood pressure and renal function in patients with type I (insulin-dependent) diabetes mellitus prior to clinical diabetic nephropathy.
    Jensen T; Borch-Johnsen K; Deckert T
    Diabetes Res; 1987 Apr; 4(4):159-62. PubMed ID: 3621799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and progression of diabetic nephropathy.
    Rossing K; Jacobsen P; Hommel E; Mathiesen E; Svenningsen A; Rossing P; Parving HH
    Diabetologia; 2002 Jan; 45(1):36-41. PubMed ID: 11845221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is antihypertensive treatment the same for NIDDM and IDDM patients?
    Parving HH
    Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
    Parving HH
    Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension in insulin-dependent diabetes.
    Norgaard K
    Dan Med Bull; 1996 Feb; 43(1):21-38. PubMed ID: 8906979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy.
    Sawicki PT; Didjurgeit U; Mühlhauser I; Heinemann L; Berger M
    J Diabet Complications; 1990; 4(4):179-83. PubMed ID: 2151231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H; Blohmé G; Grände B; Björck S
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of advanced chronic nephropathy in type 1 and type 2 diabetic and non-diabetic patients: a prospective study.
    Altman JJ; Elian N; Grun S; Gerard HG; Feldman S
    Diabetes Metab; 1999 Jun; 25(2):144-9. PubMed ID: 10443325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of diabetic nephropathy in Japanese patients with insulin-dependent diabetes mellitus: Tokyo Women's Medical College epidemiologic study.
    Yokoyama H; Uchigata Y; Otani T; Maruyama A; Yano-Aoki K; Kanematsu S; Kasahara T; Matsuura N; Omori Y
    J Diabetes Complications; 1994; 8(1):7-12. PubMed ID: 8167391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current therapeutic management of diabetic nephropathy.
    Kohler SM; Krämer BK
    Acta Diabetol; 1994 Sep; 31(3):119-25. PubMed ID: 7827347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihypertensive treatment on kidney function in diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM; Hommel E; Mathiesen ER; Svendsen PA
    Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1443-7. PubMed ID: 3111583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
    Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
    Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.